# FDA Inspection 1174486 - Stephane de Botton, M.D. - July 01, 2022

Source: https://www.keypedia.com/records/fda_inspections/stephane-de-botton-md/55eea596-007e-4e1d-b3a0-7b7deb0a1e2e
Source feed: FDA_Inspections

> FDA Inspection 1174486 for Stephane de Botton, M.D. on July 01, 2022. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1174486
- Company Name: Stephane de Botton, M.D.
- Inspection Date: 2022-07-01
- Classification: No Action Indicated (NAI)
- Project Area: Bioresearch Monitoring
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 1052873 - 2018-04-26](https://www.keypedia.com/records/fda_inspections/stephane-de-botton-md/75f9d595-9cad-47c6-82ab-885d2082eb21)
- [FDA Inspection 1014008 - 2017-04-27](https://www.keypedia.com/records/fda_inspections/stephane-de-botton-md/b0b3ac5b-4804-4491-adf3-92dc6d926286)

Company: https://www.keypedia.com/companies/stephane-de-botton-md/eb672e38-723b-4631-8049-11076f4d9d89

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c